These tweets are selected automatically with #rstats code. Please inform me if any is inappropriate. See other #OralPath pages here: https://serdarbalci.netlify.com/categories/OralPath/ or here: https://serdarbalci.wordpress.com/?s=OralPath/ See selected social media based textbook project here: http://www.patolojinotlari.com/
Pleasure! We thank you @bfaquin @ENTpathology, @Dr_OrophSCC and other top experts for this guideline...
— Merva Soluk Tekkesin (@merva_st) December 26, 2017
2. SHOULD NOT routinely perform HR-HPV testing on patients with non-SCC of the oropharynx OR nonoropharyngeal primary tumors of the head and neck.
— Merva Soluk Tekkesin (@merva_st) December 25, 2017
3. SHOULD NOT provide a tumor grade or differentiation status for HPV+/p16+ oropharyngeal SCC #HPV #oralpath #ENTPath
@bfaquin interview: HPV testing in Head and Neck Carcinomas
— Merva Soluk Tekkesin (@merva_st) December 25, 2017
https://t.co/SFo5SkjKrf #HPV #oralpath #ENTPath
3 important recommendations:
Pathologists
1. SHOULD perform HR-HPV testing on all patients with newly diagnosed oropharyngeal SCC, including all histologic subtypes
These tweets are selected automatically with #rstats code. Please inform me if any is inappropriate. See other #OralPath pages here: https://serdarbalci.netlify.com/categories/OralPath/ or here: https://serdarbalci.wordpress.com/?s=OralPath/ See selected social media based textbook project here: http://www.patolojinotlari.com/
)